Keywords
chronic kidney disease
pain intensity
Abstract
PAIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE, INCLUDING THOSE UNDERGOING RENAL REPLACEMENT THERAPY – CURRENT STATE OF KNOWLEDGE
Introduction. Chronic kidney disease is a multifaceted condition that contributes to the development of many biochemical, metabolic disorders and multi-organ pathology. Patients also experience various types of pain, often with moderate to severe intensity. Patients treated conservatively in the third or fourth stage of the disease are just as susceptible to pain as patients in the fi fth stage.
Aim. The aim of the study was present and characterize the problem of pain among patients with CKD, including patients undergoing renal replacement therapy.
Method. Review and analysis of the literature on the issue of pain among patients with PChN, including patients undergoing renal replacement therapy.
Conclusions. Musculoskeletal pain is mentioned as the most common pain symptom by both conservatively treated and dialysis patients. Kidney transplantation helps reduce the frequency of pain. The high percentage of patients suff ering from moderate to severe pain suggests that pain is ignored or ineff ectively treated. The task of doctors and nurses is to pay special attention to this adverse symptom during outpatient treatment as well as after starting renal replacement therapy.
References
1. Kidney Disease: Improving Global Outcomes (KDIGO) Lupus Nephritis Work Group. KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis. Kidney Int. 2024;105(1S):S1–S69.doi:10.1016/j.kint.2023.09.002
2. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int. Suppl. 2022;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003.
3. Gellert R. Przewlekła choroba nerek. https://medicalpress.pl/zdrowie-wspolna-sprawa/prof-ryszard-gellert-przewleka-choroba-nerek-dotyka-kadej-komrki-w-organizmie-trzeba-j-wykry-i-leczy_NlRLBXkAGe/ [Accessed 24 July 2024].
4. Elshahat S, Cockwell P, Maxwell AP, et al. The impact of chronic kidney disease on developed countries from a health economics perspective: a systematic scoping review. PLoS ONE. 2020;15(3):e0230512.doi:10.1371/journal.pone.0230512
5. Dębska-Ślizień A, Rutkowski B, Rutkowski P, et al. Current status of renal replacement therapy in Poland in 2023. Nefrol. Dial. Pol .2024;28: 3-18.
6. Fletcher BR, Damery S, Aiyegbusi OL, et al. Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis. PLoS Med. 2022;19(4):e1003954. Published 2022 Apr 6. doi:10.1371/journal.pmed.1003954
7. Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am. J. Kidney Dis. 2019;73(3 Suppl 1):A7-A8. doi:10.1053/j.ajkd.2019.01.001
8. Lambourg E, Colvin L, Guthrie G, et al. The prevalence of pain among patients with chronic kidney disease using systematic review and meta-analysis. Kidney Int. 2021;100(3):636-649. doi:10.1016/j.kint.2021.03.041
9. Wouk N. End-Stage Renal Disease: Medical Management. Am. Fam. Physician. 2021;104(5):493-499.
10. Davison SN. Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure. Clin. J. Am. Soc. Nephrol. 2019;14(6):917-931. doi:10.2215/CJN.05180418.
11. Dos Santos PR, Mendonça CR, Hernandes JC, et al. Pain in Patients With Chronic Kidney Disease Undergoing Hemodialysis: A Systematic Review. Pain Manag Nurs. 2021;22(5):605-615. doi:10.1016/j.pmn.2021.05.009
12. Jhamb M, Tucker L, Liebschutz J. When ESKD complicates the management of pain. Semin Dial. 2020;33(3):286-296. doi:10.1111/sdi.12881.
13. International Association for the Study of Pain: Terminology. https://www.iasp-pain.org/resources/terminology/ [Accessed 15 July 2024]
14. Abd-Elsayed A, Deer TR. Different Types of Pain. In: Abd-Elsayed, A. (eds.) Pain. Springer, Cham; 2019. https://doi.org/10.1007/978-3-319-99124-5_3.
15. Davison SN, Rathwell S, Ghosh S, et al. The Prevalence and Severity of Chronic Pain in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Can. J. Kidney Health Dis. 2021;8:2054358121993995. Published 2021 Feb 19. doi:10.1177/2054358121993995.
16. Brkovic T, Burilovic E, Puljak L. Prevalence and severity of pain in adult end-stage renal disease patients on chronic intermittent hemodialysis: a systematic review. Patient Prefer Adherence. 2016;10:1131-1150. Published 2016 Jun 23. doi:10.2147/PPA.S103927.
17. Viderman D, Tapinova K, Aubakirova M, et al. The Prevalence of Pain in Chronic Diseases: An Umbrella Review of Systematic Reviews. J. Clin. Med. 2023;12(23):7302. Published 2023 Nov 25. doi:10.3390/jcm12237302.
18. Yi C, Ye H, Lin J, et al. The incidence of pain and its association with quality of life in patients with peritoneal dialysis. Ren. Fail. 2022;44(1):724-730. doi:10.1080/0886022X.2022.2068444.
19. Kosmadakis G, Amara I, Costel G. Pain on arteriovenous fistula cannulation: A narrative review. Semin. Dial. 2021;00:1-10. https://doi.org/10.1111/sdi.12979.
20. Aitken E, McLellan A, Glen J, et al. Pain resulting from arteriovenous fistulae: prevalence and impact. Clin. Nephrol. 2013;80(5):328-333. doi:10.5414/CN107917.
21. Stojimirovic B, Milinkovic M, Zidverc-Trajkovic J, et al. Dialysis headache in patients undergoing peritoneal dialysis and hemodialysis. Ren Fail. 2015;37(2):241-244. doi:10.3109/0886022X.2014.982486.
22. Sousa Melo E, Pedrosa RP, Carrilho Aguiar F, et al. Dialysis headache: characteristics, impact and cerebrovascular evaluation. Arq. Neuropsiquiatr. 2022;80(2):129-136. doi:10.1590/0004-282X-ANP-2021-0133.
23. Zhang K, Hannan E, Scholes-Robertson N, et al. Patients’ perspectives of pain in dialysis: systematic review and thematic synthesis of qualitative studies. Pain. 2020;161(9):1983-1994. doi:10.1097/j.pain.0000000000001931.
24. Levy J, Morgan J, Brown E. (ed). Oxford Handbook of Dialysis, Oxford University Press 2003, pp. 348.
25. Chudek J. Bolesne skurcze mięśni, zator powietrzny, ból w klatce piersiowej. ProblemyLekarskie/Medical Problems. 2006;3:120-121.
26. Scarpioni R, Ricardi M, Albertazzi V, et al. Dialysis-related amyloidosis: challenges and solutions. Int. J. Nephrol. Renovasc. Dis. 2016;9:319-328. Published 2016 Dec 7. doi:10.2147/IJNRD.S84784.
27. Molsted S, Eidemak I. Musculoskeletal pain reported by mobile patients with chronic kidney disease. Clin. Kidney J. 2020;13(5):813-820. Published 2020 Feb 4. doi:10.1093/ckj/sfz196.
28. Hsu HJ, Yen CH, Hsu KH, et al. Factors associated with chronic musculoskeletal pain in patients with chronic kidney disease. BMC Nephrol. 2014;15:6. Published 2014 Jan 8. doi:10.1186/1471-2369-15-6.
29. Santoro D, Satta E, Messina S, et al. Pain in end-stage renal disease: a frequent and neglected clinical problem. Clin. Nephrol. 2013;79 Suppl 1:S2-S11.
30. Koncicki HM, Brennan F, Vinen K, et al. An Approach to Pain Management in End Stage Renal Disease: Considerations for General Management and Intradialytic Symptoms. Semin. Dial. 2015;28(4):384-391. doi:10.1111/sdi.12372.
31. Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of peritoneal dialysis outcomes. Nat. Rev. Nephrol. 2022;18(12):779-793. doi:10.1038/s41581-022-00623-7.
32. Arnold R, Kwai NC, Krishnan AV. Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies. Clin. Neurophysiol. 2013;124(11):2079-2090. doi:10.1016/j.clinph.2013.04.012.
33. Kaminski MR, Raspovic A, McMahon LP, et al. Risk factors for foot ulceration and lower extremity amputation in adults with end-stage renal disease on dialysis:
a systematic review and meta-analysis. Nephrol. Dial. Transplant. 2015;30(10):1747-1766. doi:10.1093/ndt/gfv114
34. Borys S.Pacjent cukrzycowy przed planowanym zabiegiem operacyjnym. Dializai Ty 2020, 3(38), 16.).
35. Yong TY, Khow KSF. Diabetic muscle infarction in end-stage renal disease: A scoping review on epidemiology, diagnosis and treatment. World J. Nephrol. 2018;7(2):58-64. doi:10.5527/wjn.v7.i2.58.
36. Chinnadurai R, Sinha S, Lowney AC, et al. Pain management in patients with end-stage renal disease and calciphylaxis- a survey of clinical practices among physicians. BMC Nephrol. 2020;21(1):403. Published 2020 Sep 18. doi:10.1186/s12882-020-02067- 2.
37. Lambourg E, Colvin L, Guthrie G, et al. Analgesic use and associated adverse events in patients with chronic kidney disease: a systematic review and meta-analysis. Br. J. Anaesth. 2022 Mar;128(3):546-561. doi: 10.1016/j.bja.2021.08.035. Epub 2021 Nov 9. PMID: 34763813.
38. Jakimowicz-Tylicka M, Chmielewski M, Kuźmiuk-Glembin I, et al. The use of over-the-counter analgesics in patients with chronic kidney disease. Eur. J. Transl. Clin. Med. 2018;1(2):11-16.DOI: 10.31373/ejtcm/99912.
39. Mulka-Gierek M, Krata N, Foroncewicz B, et al. The different patterns of over-the-counter nonsteroidal anti-inflammatory drugs or analgesics use in patients with chronic kidney disease and the general population. healthcare (Basel). 2022;10(10):2035. doi: 10.3390/healthcare10102035. PMID: 36292481; PMCID: PMC9602380.
40. Lu E, Koncicki HM. Nonopioid approaches to pain management in chronic kidney disease. Semin. Nephrol. 2021;41(1):54-67. doi: 10.1016/j.semnephrol.2021.02.006. PMID: 33896474.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Authors